AMANDA LUCKOCK: Open Payments
NPI 1366044935 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 22 payments from 8 companies in 2025. Trend: 2023 $118 · 2024 $677 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $152 |
| Novo Nordisk Inc | 3 | $74 |
| Lundbeck LLC | 3 | $65 |
| Insulet Corporation | 1 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Viatris Specialty LLC | 1 | $22 |
| Corcept Therapeutics | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $9 |
Products named: VRAYLAR, REXULTI, Omnipod, Wegovy, QULIPTA, COBENFY, MAVYRET, YUPELRI.
Industry payments across ID — which companies pay providers there.
